Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network 

October 24, 2023 — 

The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with AbbVie Inc. for the Phase 3 development of upadacitinib (RINVOQ®) as a potential treatment for people living with systemic lupus erythematosus (SLE). Lupus Therapeutics will assist with recruiting participants to join the study, activation of each study site and engaging sites to join the study through the Lupus Clinical Investigators Network (LuCIN) of top academic centers throughout North America.

The full press release is available on the Lupus Therapeutics website.

Read full Press Release

Recent Stories & News

Story
Lupus Research Alliance and Clinical Affiliate Lupus Therapeutics Selected as Inaugural Strategic Collaborators with Vie Ventures to Advance Innovative Autoimmune Therapies   
July 9, 2025
The Lupus Research Alliance and clinical affiliate Lupus Therapeutics are proud to be selected as inaugural collaborators of the...
Story
Lupus Research Alliance Honors the Life of its Former Leader Margaret G. Dowd
June 26, 2025
The Lupus Research Alliance mourns the death of Margaret “Peggy” G. Dowd, its former Co-President and Co-CEO and relentless...
Press Release
LRA Awards 2025 Lupus Insight Prize to Dr. Deepak Rao for Uncovering Key Drivers of Immune Imbalance in Lupus
June 25, 2025
The Lupus Research Alliance (LRA) proudly awarded the 2025 Lupus Insight Prize today to highly respected immunologist Deepak Rao,...